The NCCN Quality and Outcomes Committee was first founded in 2016 in order to develop quality and outcome measures in oncology that are:
The committee reviewed 528 existing oncology quality measures and new measure concepts that could be appropriate for development. This list was narrowed down into 22 recommendations–based on importance, supporting evidence, opportunity for improvement, and ease of measurement–including endorsement of 15 existing measures and seven new concepts proposed for development.
“These recommendations from NCCN differ from certification programs–we are sharing them free-of-charge to allow cancer programs everywhere to be more efficient and focused with their resources while tracking quality improvements,” explained Robert W. Carlson, MD, Chief Executive Officer, NCCN. “There’s a concerted effort toward value-based care; we want to ensure that these payment models reduce costs without reducing quality, and in fact improve outcomes. The current landscape for quality measurements is broad, and it’s difficult to know how to prioritize for quality improvements. This framework from NCCN aligns processes for measuring attainable cancer care improvements that will translate into better outcomes for patients.”
Read more…